Trial Site Detail

 

Drug:
PF-052112384 + PD-0325901 OR PF-052112384 + Irinotecan
Trial:
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Conditions: Solid Tumors
Trial Status:
Terminated

 

Site name unknown Charleston 29425

     
Charleston , SC 29425
USA

 

Principal Investigator:
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Site name unknown Charleston 29425 Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.